Return on Equity (ROE)
Updated 510h ago
Sector Performance
11th percentileLYB
-6.0%
Sector Median
13.8%
Sector Avg
31.4%
Deep Analysis
A Return on Equity (ROE) of -6.0% means the company generated a net loss of $6 for every $100 of shareholder equity over the past twelve months, indicating it is not earning a profit on the money investors have put in.
This is well below the sector median of 13.9%, placing it at the 11th percentile among peers—meaning 89% of competitors have a higher ROE. The year-over-year change is not available, but the quarter-over-quarter change shows an improvement of +18.9%, from -7.4% to -6.0%. While the negative level signals financial stress, the upward quarterly trend hints at a potential bottoming process, which reduces some immediate risk but does not eliminate it. This combination of a weak absolute ROE with a recent improvement does not contradict the overall NEUTRAL verdict, as the stock is neither clearly failing nor decisively recovering.
Frequently Asked Questions
What does the Return on Equity (ROE) tell investors about LYB?
ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.
How is the Return on Equity (ROE) calculated?
Return on Equity (ROE) is calculated as: Net Income / Shareholders' Equity.
Who are LYB's closest peers by Return on Equity (ROE)?
The closest peers by Return on Equity (ROE) include: MRNA (-36.6%), FICO (-37.3%), XRAY (-37.7%), VRSN (-38.3%), MSCI (-45.3%).
The Formula
Net Income / Shareholders' Equity
Why It Matters
ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.
Master LYB's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full LYB research report →LYB
-6.0%
Sector Median
13.8%
Sector Avg
31.4%
How LYB's Return on Equity (ROE) compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.